NASDAQ · Healthcare · Medical - Devices
Cytosorbents Corporation
CTSO
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. CEO Phillip Chan · Market cap $22.7M.
$0.36
-0.10 · -21.30%
52w hi $1.3052w lo $0.36
Off 52w high 62.7%
65
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 15 | Peter J Mariani | Chief Financial Officer | Buy | 100,000 | $0.44 | +$44K | 57 |
| Jun 12 | Phillip P. Chan | Chief Executive Officer | Buy | 251,136 | $0.40 | +$100K | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun